Biotechnology-Europe Market Status and Trend Report 2013-2023
SKU ID :MI-12068076 | Published Date: 01-Apr-2018 | No. of pages: 131Description
TOC
Table of Contents
Chapter 1 Overview of Biotechnology
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 Europe Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
Chapter 2 Europe Market Status and Forecast by Regions
2.1 Market Status of Biotechnology in Europe 2013-2017
2.2 Consumption Market of Biotechnology in Europe by Regions
2.2.1 Consumption Volume of Biotechnology in Europe by Regions
2.2.2 Revenue of Biotechnology in Europe by Regions
2.3 Market Analysis of Biotechnology in Europe by Regions
2.3.1 Market Analysis of Biotechnology in Germany 2013-2017
2.3.2 Market Analysis of Biotechnology in United Kingdom 2013-2017
2.3.3 Market Analysis of Biotechnology in France 2013-2017
2.3.4 Market Analysis of Biotechnology in Italy 2013-2017
2.3.5 Market Analysis of Biotechnology in Spain 2013-2017
2.3.6 Market Analysis of Biotechnology in Benelux 2013-2017
2.3.7 Market Analysis of Biotechnology in Russia 2013-2017
2.4 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.1 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023
Chapter 3 Europe Market Status and Forecast by Types
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Biotechnology in Europe by Types
3.1.2 Revenue of Biotechnology in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Biotechnology in Europe by Types
Chapter 4 Europe Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Biotechnology in Europe by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biotechnology by Downstream Industry in Germany
4.2.2 Demand Volume of Biotechnology by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Biotechnology by Downstream Industry in France
4.2.4 Demand Volume of Biotechnology by Downstream Industry in Italy
4.2.5 Demand Volume of Biotechnology by Downstream Industry in Spain
4.2.6 Demand Volume of Biotechnology by Downstream Industry in Benelux
4.2.7 Demand Volume of Biotechnology by Downstream Industry in Russia
4.3 Market Forecast of Biotechnology in Europe by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biotechnology
5.1 Europe Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview
Chapter 6 Biotechnology Market Competition Status by Major Players in Europe
6.1 Sales Volume of Biotechnology in Europe by Major Players
6.2 Revenue of Biotechnology in Europe by Major Players
6.3 Basic Information of Biotechnology by Major Players
6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Biotechnology Major Manufacturers Introduction and Market Data
7.1 Johnson & Johnson Services, Inc.
7.1.1 Company profile
7.1.2 Representative Biotechnology Product
7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company profile
7.2.2 Representative Biotechnology Product
7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biotechnology Product
7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Biotechnology Product
7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Biotechnology Product
7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Biotechnology Product
7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
7.7.1 Company profile
7.7.2 Representative Biotechnology Product
7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
7.8.1 Company profile
7.8.2 Representative Biotechnology Product
7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
7.9.1 Company profile
7.9.2 Representative Biotechnology Product
7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
7.10.1 Company profile
7.10.2 Representative Biotechnology Product
7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
7.11.1 Company profile
7.11.2 Representative Biotechnology Product
7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
7.12.1 Company profile
7.12.2 Representative Biotechnology Product
7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
7.13.1 Company profile
7.13.2 Representative Biotechnology Product
7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
7.14.1 Company profile
7.14.2 Representative Biotechnology Product
7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
Chapter 8 Upstream and Downstream Market Analysis of Biotechnology
8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biotechnology
9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology
Chapter 10 Marketing Status Analysis of Biotechnology
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of DNA Sequencing
Table Advantage and Disadvantage of Nanobiotechnology
Table Advantage and Disadvantage of Tissue engineering and Regeneration
Table Advantage and Disadvantage of Fermentation
Table Advantage and Disadvantage of Cell Based Assay
Table Advantage and Disadvantage of PCR Technology
Table Advantage and Disadvantage of Chromatography Market
Table Advantage and Disadvantage of Others
Table Consumption Volume of Biotechnology in Europe by Regions 2013-2017
Table Revenue of Biotechnology in Europe by Regions 2013-2017
Table Consumption Volume of Biotechnology in Europe by Regions 2018-2023
Table Revenue of Biotechnology in Europe by Regions 2018-2023
Table Consumption Volume of Biotechnology in Europe by Types 2013-2017
Table Revenue of Biotechnology in Europe by Types 2013-2017
Table Consumption Volume of Biotechnology by Types in Germany 2013-2017
Table Consumption Volume of Biotechnology by Types in United Kingdom 2013-2017
Table Consumption Volume of Biotechnology by Types in France 2013-2017
Table Consumption Volume of Biotechnology by Types in Italy 2013-2017
Table Consumption Volume of Biotechnology by Types in Spain 2013-2017
Table Consumption Volume of Biotechnology by Types in Benelux 2013-2017
Table Consumption Volume of Biotechnology by Types in Russia 2013-2017
Table Consumption Volume Forecast of Biotechnology in Europe by Types 2018-2023
Table Revenue Forecast of Biotechnology in Europe by Types 2018-2023
Table Demand Volume of Biotechnology in Europe by Downstream Industry 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in Germany 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in United Kingdom 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in France 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in Italy 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in Spain 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in Benelux 2013-2017
Table Demand Volume of Biotechnology by Downstream Industry in Russia 2013-2017
Table Demand Volume Forecast of Biotechnology in Europe by Downstream Industry 2018-2023
Table Sales Volume of Biotechnology in Europe by Major Players 2013-2017
Table Revenue of Biotechnology in Europe by Major Players 2013-2017
Table Headquarters Location and Established Time of Biotechnology Major Players
Table Employees and Revenue Level of Biotechnology Major Players
Table Representative Biotechnology Product One of Johnson & Johnson Services, Inc.
Table Representative Biotechnology Product Two of Johnson & Johnson Services, Inc.
Table Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc. 2013-2017
Table Representative Biotechnology Product One of F. Hoffmann-La Roche Ltd
Table Representative Biotechnology Product Two of F. Hoffmann-La Roche Ltd
Table Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 2013-2017
Table Representative Biotechnology Product One of Pfizer
Table Representative Biotechnology Product Two of Pfizer
Table Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017
Table Representative Biotechnology Product One of Merck & Co.
Table Representative Biotechnology Product Two of Merck & Co.
Table Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co. 2013-2017
Table Representative Biotechnology Product One of Sanofi
Table Representative Biotechnology Product Two of Sanofi
Table Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017
Table Representative Biotechnology Product One of AstraZeneca
Table Representative Biotechnology Product Two of AstraZeneca
Table Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017
Table Representative Biotechnology Product One of Gilead
Table Representative Biotechnology Product Two of Gilead
Table Biotechnology Sales, Revenue, Price and Gross Margin of Gilead 2013-2017
Table Representative Biotechnology Product One of CELGENE CORPORATION
Table Representative Biotechnology Product Two of CELGENE CORPORATION
Table Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION 2013-2017
Table Representative Biotechnology Product One of Biogen
Table Representative Biotechnology Product Two of Biogen
Table Biotechnology Sales, Revenue, Price and Gross Margin of Biogen 2013-2017
Table Representative Biotechnology Product One of Amgen, Inc
Table Representative Biotechnology Product Two of Amgen, Inc
Table Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc 2013-2017
Table Representative Biotechnology Product One of Abbott
Table Representative Biotechnology Product Two of Abbott
Table Biotechnology Sales, Revenue, Price and Gross Margin of Abbott 2013-2017
Table Representative Biotechnology Product One of Novo Nordisk A/S
Table Representative Biotechnology Product Two of Novo Nordisk A/S
Table Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S 2013-2017
Table Representative Biotechnology Product One of Novartis AG
Table Representative Biotechnology Product Two of Novartis AG
Table Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG 2013-2017
Table Representative Biotechnology Product One of Lonza
Table Representative Biotechnology Product Two of Lonza
Table Biotechnology Sales, Revenue, Price and Gross Margin of Lonza 2013-2017
Companies
- PRICE
-
$3480$5980Buy Now